Literature DB >> 9395238

Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.

B Göttgens1, F McLaughlin, E O Bockamp, J L Fordham, C G Begley, K Kosmopoulos, A G Elefanty, A R Green.   

Abstract

The SCL gene (also known as TAL-1) encodes a basic helix-loop-helix transcription factor that is essential for the development of all haematopoietic lineages, and ectopic expression of which results in T cell leukaemia. SCL is expressed in normal pluripotent haematopoietic stem cells and its expression is maintained during differentiation along erythroid, mast and megakaryocytic lineages, but is extinguished following commitment to other cell types. The mechanisms responsible for this pattern of expression are poorly understood, but are likely to illuminate the molecular basis for stem cell development and lineage commitment. We have identified multiple lineage-restricted DNase I hypersensitive sites in a 45 kb region spanning the murine SCL locus. Committed erythroid cells and CD34 positive primitive myeloid cells exhibited both shared and unique DNase I hypersensitive sites whereas none were found in T cells. The function of each hypersensitive site was studied using both transient and stable reporter assays in erythroid, primitive myeloid and T cells. Multiple positive and negative regulatory elements were characterised and found to display lineage-specificity, promoter-specificity and/or chromatin-dependence. These results represent the first description of key components of a complex network of regulatory elements controlling SCL expression during haematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395238     DOI: 10.1038/sj.onc.1201426

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  Long-range comparison of human and mouse SCL loci: localized regions of sensitivity to restriction endonucleases correspond precisely with peaks of conserved noncoding sequences.

Authors:  B Göttgens; J G Gilbert; L M Barton; D Grafham; J Rogers; D R Bentley; A R Green
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

2.  Mapping of complex regulatory elements by pufferfish/zebrafish transgenesis.

Authors:  E V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

3.  Transcriptional regulation of the stem cell leukemia gene (SCL)--comparative analysis of five vertebrate SCL loci.

Authors:  Berthold Göttgens; Linda M Barton; Michael A Chapman; Angus M Sinclair; Bjarne Knudsen; Darren Grafham; James G R Gilbert; Jane Rogers; David R Bentley; Anthony R Green
Journal:  Genome Res       Date:  2002-05       Impact factor: 9.043

4.  The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.

Authors:  Berthold Göttgens; Cyril Broccardo; Maria-Jose Sanchez; Sophie Deveaux; George Murphy; Joachim R Göthert; Ekaterini Kotsopoulou; Sarah Kinston; Liz Delaney; Sandie Piltz; Linda M Barton; Kathy Knezevic; Wendy N Erber; C Glenn Begley; Jonathan Frampton; Anthony R Green
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

5.  Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo.

Authors:  E Delabesse; S Ogilvy; M A Chapman; S G Piltz; B Gottgens; A R Green
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

6.  Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites.

Authors:  George A Follows; Pawan Dhami; Berthold Göttgens; Alexander W Bruce; Peter J Campbell; Shane C Dillon; Aileen M Smith; Christoph Koch; Ian J Donaldson; Mike A Scott; Ian Dunham; Mary E Janes; David Vetrie; Anthony R Green
Journal:  Genome Res       Date:  2006-09-08       Impact factor: 9.043

7.  Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells.

Authors:  John E Pimanda; Lev Silberstein; Massimo Dominici; Benjamin Dekel; Mark Bowen; Scott Oldham; Asha Kallianpur; Stephen J Brandt; David Tannahill; Berthold Göttgens; Anthony R Green
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Genomic approaches uncover increasing complexities in the regulatory landscape at the human SCL (TAL1) locus.

Authors:  Pawandeep Dhami; Alexander W Bruce; Johanna H Jim; Shane C Dillon; Amanda Hall; Jonathan L Cooper; Nicolas Bonhoure; Kelly Chiang; Peter D Ellis; Cordelia Langford; Robert M Andrews; David Vetrie
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

9.  Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation.

Authors:  Fernando J Calero-Nieto; Andrew D Wood; Nicola K Wilson; Sarah Kinston; Josette-Renée Landry; Berthold Göttgens
Journal:  Nucleic Acids Res       Date:  2010-06-04       Impact factor: 16.971

10.  A novel mode of enhancer evolution: the Tal1 stem cell enhancer recruited a MIR element to specifically boost its activity.

Authors:  Aileen M Smith; Maria-Jose Sanchez; George A Follows; Sarah Kinston; Ian J Donaldson; Anthony R Green; Berthold Göttgens
Journal:  Genome Res       Date:  2008-08-07       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.